181 related articles for article (PubMed ID: 36302800)
1. Neuromedin U-deficient rats do not lose body weight or food intake.
Yokogi K; Goto Y; Otsuka M; Ojima F; Kobayashi T; Tsuchiba Y; Takeuchi Y; Namba M; Kohno M; Tetsuka M; Takeuchi S; Matsuyama M; Aizawa S
Sci Rep; 2022 Oct; 12(1):17472. PubMed ID: 36302800
[TBL] [Abstract][Full Text] [Related]
2. Neuromedin U receptor 2 knockdown in the paraventricular nucleus modifies behavioral responses to obesogenic high-fat food and leads to increased body weight.
Benzon CR; Johnson SB; McCue DL; Li D; Green TA; Hommel JD
Neuroscience; 2014 Jan; 258():270-9. PubMed ID: 24269937
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of neuromedin U mRNA expression in the rat pars tuberalis by melatonin.
Aizawa S; Sakata I; Nagasaka M; Higaki Y; Sakai T
PLoS One; 2013; 8(7):e67118. PubMed ID: 23843987
[TBL] [Abstract][Full Text] [Related]
4. Negative energy balance and leptin regulate neuromedin-U expression in the rat pars tuberalis.
Nogueiras R; Tovar S; Mitchell SE; Barrett P; Rayner DV; Dieguez C; Williams LM
J Endocrinol; 2006 Aug; 190(2):545-53. PubMed ID: 16899587
[TBL] [Abstract][Full Text] [Related]
5. The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).
Peier A; Kosinski J; Cox-York K; Qian Y; Desai K; Feng Y; Trivedi P; Hastings N; Marsh DJ
Endocrinology; 2009 Jul; 150(7):3101-9. PubMed ID: 19324999
[TBL] [Abstract][Full Text] [Related]
6. Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.
Kaisho T; Nagai H; Asakawa T; Suzuki N; Fujita H; Matsumiya K; Nishizawa N; Kanematsu-Yamaki Y; Dote K; Sakamoto JI; Asami T; Takekawa S
Int J Obes (Lond); 2017 Dec; 41(12):1790-1797. PubMed ID: 28757640
[TBL] [Abstract][Full Text] [Related]
7. Neuromedin U inhibits food intake partly by inhibiting gastric emptying.
Dalbøge LS; Pedersen SL; Secher T; Holst B; Vrang N; Jelsing J
Peptides; 2015 Jul; 69():56-65. PubMed ID: 25895852
[TBL] [Abstract][Full Text] [Related]
8. Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in mice.
Egecioglu E; Ploj K; Xu X; Bjursell M; Salomé N; Andersson N; Ohlsson C; Taube M; Hansson C; Bohlooly-Y M; Morgan DG; Dickson SL
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E708-16. PubMed ID: 19584200
[TBL] [Abstract][Full Text] [Related]
9. Brain region-specific neuromedin U signalling regulates alcohol-related behaviours and food intake in rodents.
Vallöf D; Kalafateli AL; Jerlhag E
Addict Biol; 2020 May; 25(3):e12764. PubMed ID: 31069918
[TBL] [Abstract][Full Text] [Related]
10. Effects of peripherally administered neuromedin U on energy and glucose homeostasis.
Peier AM; Desai K; Hubert J; Du X; Yang L; Qian Y; Kosinski JR; Metzger JM; Pocai A; Nawrocki AR; Langdon RB; Marsh DJ
Endocrinology; 2011 Jul; 152(7):2644-54. PubMed ID: 21586559
[TBL] [Abstract][Full Text] [Related]
11. Appetite-modifying actions of pro-neuromedin U-derived peptides.
Bechtold DA; Ivanov TR; Luckman SM
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E545-51. PubMed ID: 19531638
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity.
Novak CM; Zhang M; Levine JA
Brain Res; 2007 Sep; 1169():57-68. PubMed ID: 17706946
[TBL] [Abstract][Full Text] [Related]
13. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2.
Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR
J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576
[TBL] [Abstract][Full Text] [Related]
14. Neuromedin U partly mimics thyroid-stimulating hormone and triggers Wnt/β-catenin signalling in the photoperiodic response of F344 rats.
Helfer G; Ross AW; Morgan PJ
J Neuroendocrinol; 2013 Dec; 25(12):1264-1272. PubMed ID: 24164054
[TBL] [Abstract][Full Text] [Related]
15. Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding.
Zeng H; Gragerov A; Hohmann JG; Pavlova MN; Schimpf BA; Xu H; Wu LJ; Toyoda H; Zhao MG; Rohde AD; Gragerova G; Onrust R; Bergmann JE; Zhuo M; Gaitanaris GA
Mol Cell Biol; 2006 Dec; 26(24):9352-63. PubMed ID: 17030627
[TBL] [Abstract][Full Text] [Related]
16. Ovarian regulation of neuromedin U and its local actions in the ovary, mediated through neuromedin U receptor 2.
Lin TY; Wu FJ; Lee WY; Hsiao CL; Luo CW
Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E800-9. PubMed ID: 23423171
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of neuromedin U actions in energy homeostasis and pituitary function.
Ivanov TR; Lawrence CB; Stanley PJ; Luckman SM
Endocrinology; 2002 Oct; 143(10):3813-21. PubMed ID: 12239092
[TBL] [Abstract][Full Text] [Related]
18. The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior.
Botticelli L; Micioni Di Bonaventura E; Del Bello F; Giorgioni G; Piergentili A; Quaglia W; Bonifazi A; Cifani C; Micioni Di Bonaventura MV
Pharmacol Res; 2023 Sep; 195():106875. PubMed ID: 37517560
[TBL] [Abstract][Full Text] [Related]
19. Gamma-Aminobutyric Acidergic Projections From the Dorsal Raphe to the Nucleus Accumbens Are Regulated by Neuromedin U.
Kasper JM; McCue DL; Milton AJ; Szwed A; Sampson CM; Huang M; Carlton S; Meltzer HY; Cunningham KA; Hommel JD
Biol Psychiatry; 2016 Dec; 80(11):878-887. PubMed ID: 27105831
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway.
Garczyk S; Klotz N; Szczepanski S; Denecke B; Antonopoulos W; von Stillfried S; Knüchel R; Rose M; Dahl E
Oncotarget; 2017 May; 8(22):36246-36265. PubMed ID: 28423716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
